Sezary Syndrome Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Clinical Trials

Testing the Addition of an Anti-cancer Drug, Hu5F9-G4 (Magrolimab), to the Usual Chemotherapy Treatment (Mogamulizumab) in T-Cell (a Type of Immune Cell) Lymphoma That Has Returned After or Does Not Respond to Treatment
Conditions:   Recurrent Mycosis Fungoides;   Recurrent Mycosis Fungoides and Sezary Syndrome;   Refractory Mycosis Fungoides;   Refractory Mycosis Fungoides and Sezary Syndrome;   Sezary Syndrome;   Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8;   Stage II Mycosis Fungoides and S ezary Syndrome AJCC v8;   Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8;   Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8;   Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8;   Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v8;   Stage IIIB Mycosis Fungoides and Sezary Syndrome A...
Source: ClinicalTrials.gov - September 9, 2020 Category: Research Source Type: clinical trials